In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Hot Line IV - Myocardial Infarction

ESC Congress 2014, Barcelona - press conference

Date & Time:  Monday 01 September, 09:00-10:00
Refers to session: Hot Line IV - Myocardial Infarction

Chairpersons
Prof. Lars Wallentin (Sweden)
Dr. Elliott Antman (USA)
Spokespersons
Prof. Kurt Huber (Austria)
Prof. Steen D. Kristensen (Denmark)

 

 



Complete versus Lesion only PRimary -PCI Trial  (CvLPRIT): Treat the infarct related artery only or all lesions

Prof. Anthony Gershlick, Glenfield Hospital (UK)
Press release  |  Slides

 

 

The British Heart Foundation Fractional Flow Reserve versus Angiography in Guiding Management to Optimise Outcomes in Non-ST-Segment Elevation Myocardial Infarction (FAMOUS trial)

Prof. Colin Berry, University Of Glasgow (Glasgow, UK)
Press release  |  Slides

 

 

Nitric oxide for inhalation to reduce reperfusion injury in acute st-elevation myocardial infarction - NOMI Study

Prof. Stefan Janssens, University Hospital Gasthuisberg of Leuven (Leuven, Belgium)
Press release  |  Slides

 

 

Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the MITOCARE study 

Prof. Dan Atar, Oslo University Hospital Ulleval (Oslo, Norway)
Press release  |  Slides

 

 

In-ambulance versus in-cath lab administration of ticagrelor in STEMI patients transferred for primary PCI: the randomized, double-blind ATLANTIC study

Prof. Gilles Montalescot, Pitié-Salpetrière University Hospital (Paris, France)
Press release  |  Slides 

 

 



Abstracts linked to ESC press conferences are not available until embargo lifts. The embargo lifts at the beginning of the press conference or the scientific session, whichever comes first. All other abstracts will be online on 22 August, 2014 in the Scientific Programme Planner except for Hot Lines, Clinical Trial Update and Registries Hot Lines abstracts.
Press releases are available on site in the press kit (USB key) that you will receive once you pick up your badge at the press registration desk at ESC Congress 2014 - except for press releases on Clinical Trial Updates and Hot Line sessions which are only available when the embargo lifts.
Press slides will be available at the beginning of the press conference.
All ESC Press conferences will be broadcasted live. Unfortunately, no webcast will be available. Access to the session will be restricted to registered press only.
During the ESC Congress 2014, all scientific resources are available on ESC Congress 365.